Free Trial

Theracryf (TCF) Competitors

GBX 0.23 -0.02 (-6.12%)
As of 05/15/2026 12:25 PM Eastern

TCF vs. ING, HARL, NWT, SPO, and IX

Should you buy Theracryf stock or one of its competitors? MarketBeat compares Theracryf with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Theracryf include Ingenta (ING), Harland & Wolff Group (HARL), Newmark Security (NWT), Sportech (SPO), and i(x) Net Zero (IX). These companies are all part of the "banking" industry.

How does Theracryf compare to Ingenta?

Ingenta (LON:ING) and Theracryf (LON:TCF) are both small-cap banking companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

Ingenta has higher revenue and earnings than Theracryf. Theracryf is trading at a lower price-to-earnings ratio than Ingenta, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ingenta£10.27M1.41£1.34M£11.998.34
TheracryfN/AN/A-£5.45M-£0.13N/A

In the previous week, Ingenta's average media sentiment score of 0.00 equaled Theracryf'saverage media sentiment score.

Company Overall Sentiment
Ingenta Neutral
Theracryf Neutral

Ingenta has a net margin of 16.94% compared to Theracryf's net margin of -792.17%. Ingenta's return on equity of 24.87% beat Theracryf's return on equity.

Company Net Margins Return on Equity Return on Assets
Ingenta16.94% 24.87% 7.54%
Theracryf -792.17%-37.30%-48.26%

12.6% of Ingenta shares are owned by institutional investors. Comparatively, 2.2% of Theracryf shares are owned by institutional investors. 76.8% of Ingenta shares are owned by company insiders. Comparatively, 23.1% of Theracryf shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Ingenta has a beta of 0.676, indicating that its share price is 32% less volatile than the broader market. Comparatively, Theracryf has a beta of 1.402, indicating that its share price is 40% more volatile than the broader market.

Summary

Ingenta beats Theracryf on 9 of the 10 factors compared between the two stocks.

How does Theracryf compare to Harland & Wolff Group?

Theracryf (LON:TCF) and Harland & Wolff Group (LON:HARL) are both small-cap banking companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

2.2% of Theracryf shares are held by institutional investors. Comparatively, 60.8% of Harland & Wolff Group shares are held by institutional investors. 23.1% of Theracryf shares are held by company insiders. Comparatively, 16.3% of Harland & Wolff Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Theracryf has higher earnings, but lower revenue than Harland & Wolff Group. Theracryf is trading at a lower price-to-earnings ratio than Harland & Wolff Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TheracryfN/AN/A-£5.45M-£0.13N/A
Harland & Wolff Group£86.91M0.00-£43.09M-£0.24N/A

In the previous week, Theracryf's average media sentiment score of 0.00 equaled Harland & Wolff Group'saverage media sentiment score.

Company Overall Sentiment
Theracryf Neutral
Harland & Wolff Group Neutral

Harland & Wolff Group has a net margin of -49.57% compared to Theracryf's net margin of -792.17%. Harland & Wolff Group's return on equity of 0.00% beat Theracryf's return on equity.

Company Net Margins Return on Equity Return on Assets
Theracryf-792.17% -37.30% -48.26%
Harland & Wolff Group -49.57%N/A -16.78%

Theracryf has a beta of 1.402, suggesting that its share price is 40% more volatile than the broader market. Comparatively, Harland & Wolff Group has a beta of 3.14, suggesting that its share price is 214% more volatile than the broader market.

Summary

Harland & Wolff Group beats Theracryf on 6 of the 10 factors compared between the two stocks.

How does Theracryf compare to Newmark Security?

Newmark Security (LON:NWT) and Theracryf (LON:TCF) are both small-cap banking companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

In the previous week, Newmark Security's average media sentiment score of 0.00 equaled Theracryf'saverage media sentiment score.

Company Overall Sentiment
Newmark Security Neutral
Theracryf Neutral

53.3% of Newmark Security shares are owned by institutional investors. Comparatively, 2.2% of Theracryf shares are owned by institutional investors. 52.3% of Newmark Security shares are owned by company insiders. Comparatively, 23.1% of Theracryf shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Newmark Security has a net margin of 4.19% compared to Theracryf's net margin of -792.17%. Newmark Security's return on equity of 11.74% beat Theracryf's return on equity.

Company Net Margins Return on Equity Return on Assets
Newmark Security4.19% 11.74% 2.75%
Theracryf -792.17%-37.30%-48.26%

Newmark Security has higher revenue and earnings than Theracryf. Theracryf is trading at a lower price-to-earnings ratio than Newmark Security, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Newmark Security£24.37M0.35£134.00K£10.488.59
TheracryfN/AN/A-£5.45M-£0.13N/A

Newmark Security has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market. Comparatively, Theracryf has a beta of 1.402, indicating that its share price is 40% more volatile than the broader market.

Summary

Newmark Security beats Theracryf on 9 of the 10 factors compared between the two stocks.

How does Theracryf compare to Sportech?

Sportech (LON:SPO) and Theracryf (LON:TCF) are both small-cap banking companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

In the previous week, Sportech's average media sentiment score of 0.00 equaled Theracryf'saverage media sentiment score.

Company Overall Sentiment
Sportech Neutral
Theracryf Neutral

61.3% of Sportech shares are owned by institutional investors. Comparatively, 2.2% of Theracryf shares are owned by institutional investors. 31.4% of Sportech shares are owned by insiders. Comparatively, 23.1% of Theracryf shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Sportech has a net margin of 2.47% compared to Theracryf's net margin of -792.17%. Sportech's return on equity of -3.95% beat Theracryf's return on equity.

Company Net Margins Return on Equity Return on Assets
Sportech2.47% -3.95% 0.31%
Theracryf -792.17%-37.30%-48.26%

Sportech has higher revenue and earnings than Theracryf. Theracryf is trading at a lower price-to-earnings ratio than Sportech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sportech£26.98M0.00-£1.01M-£0.05N/A
TheracryfN/AN/A-£5.45M-£0.13N/A

Sportech has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market. Comparatively, Theracryf has a beta of 1.402, suggesting that its stock price is 40% more volatile than the broader market.

Summary

Sportech beats Theracryf on 8 of the 10 factors compared between the two stocks.

How does Theracryf compare to i(x) Net Zero?

Theracryf (LON:TCF) and i(x) Net Zero (LON:IX) are both small-cap banking companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

i(x) Net Zero has higher revenue and earnings than Theracryf. Theracryf is trading at a lower price-to-earnings ratio than i(x) Net Zero, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TheracryfN/AN/A-£5.45M-£0.13N/A
i(x) Net Zero£80.05M0.00£56.40M£0.54N/A

In the previous week, Theracryf's average media sentiment score of 0.00 equaled i(x) Net Zero'saverage media sentiment score.

Company Overall Sentiment
Theracryf Neutral
i(x) Net Zero Neutral

2.2% of Theracryf shares are held by institutional investors. 23.1% of Theracryf shares are held by company insiders. Comparatively, 45.4% of i(x) Net Zero shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

i(x) Net Zero has a net margin of 70.33% compared to Theracryf's net margin of -792.17%. i(x) Net Zero's return on equity of 60.99% beat Theracryf's return on equity.

Company Net Margins Return on Equity Return on Assets
Theracryf-792.17% -37.30% -48.26%
i(x) Net Zero 70.33%60.99%39.94%

Theracryf has a beta of 1.402, meaning that its stock price is 40% more volatile than the broader market. Comparatively, i(x) Net Zero has a beta of 1.94, meaning that its stock price is 94% more volatile than the broader market.

Summary

i(x) Net Zero beats Theracryf on 9 of the 10 factors compared between the two stocks.

Get Theracryf News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TCF vs. The Competition

MetricTheracryfBiotechnology IndustryMedical SectorLON Exchange
Market Cap£5.05M£466.99M£6.42B£2.60B
Dividend YieldN/A3.86%2.80%6.15%
P/E Ratio-1.773.8720.40365.91
Price / SalesN/A7,766.11566.1588,030.08
Price / CashN/A13.1343.0427.89
Price / Book0.2784.219.877.74
Net Income-£5.45M-£96.07M£3.57B£5.89B
7 Day Performance4.55%0.98%0.31%0.21%
1 Month Performance-5.74%0.43%-1.27%1.56%
1 Year Performance-8.00%69.18%33.54%77.95%

Theracryf Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TCF
Theracryf
N/AGBX 0.23
-6.1%
N/A-11.5%£5.05MN/AN/A10
ING
Ingenta
N/AGBX 100
+2.0%
N/A+52.7%£14.51M£10.27M8.3465,000
HARL
Harland & Wolff Group
N/AN/AN/AN/A£14.49M£86.91MN/A81
NWT
Newmark Security
N/AGBX 90
-7.7%
N/A+6.0%£8.48M£24.37M8.59102
SPO
Sportech
N/AN/AN/AN/A£8.40M£26.98MN/A217,000

Related Companies and Tools


This page (LON:TCF) was last updated on 5/16/2026 by MarketBeat.com Staff.
From Our Partners